Distinguishing Closely Related Pancreatic Cancer Subtypes In Vivo by 13C Glucose MRI without Hyperpolarization
暂无分享,去创建一个
James B. Mitchell | Albert P. Chen | P. Choyke | H. Merkle | J. Ardenkjaer-Larsen | J. Brender | S. Matsumoto | G. Reed | M. Krishna | J. Munasinghe | S. Kishimoto | Keita Saito | Tomohiro Seki | Nobu Oshima | Kazu Yamamoto | A. Chen
[1] H. Kocher,et al. Pancreatic Cancer , 2019, Methods in Molecular Biology.
[2] R. Fulbright,et al. Deuterium metabolic imaging (DMI) for MRI-based 3D mapping of metabolism in vivo , 2018, Science Advances.
[3] James B. Mitchell,et al. Metabolic and Physiologic Imaging Biomarkers of the Tumor Microenvironment Predict Treatment Outcome with Radiation or a Hypoxia-Activated Prodrug in Mice. , 2018, Cancer research.
[4] Albert P. Chen,et al. PET by MRI: Glucose Imaging by 13C-MRS without Dynamic Nuclear Polarization by Noise Suppression through Tensor Decomposition Rank Reduction , 2018, bioRxiv.
[5] Y. Ling,et al. Palliative treatment efficacy of glucose inhibition combined with chemotherapy for non-small cell lung cancer with widespread bone and brain metastases: A case report. , 2017, Biomedical reports.
[6] D. Urban,et al. Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH). , 2017, Journal of medicinal chemistry.
[7] Nicolas Poté,et al. Tumor Heterogeneity in Pancreatic Adenocarcinoma , 2017, Pathobiology.
[8] Gerald C. Chu,et al. Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism , 2017, Nature Communications.
[9] M. Falasca,et al. Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies , 2017, International journal of molecular sciences.
[10] Jeffrey E. Lee,et al. Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma , 2017, PloS one.
[11] E. Collisson,et al. Stromal cues regulate the pancreatic cancer epigenome and metabolome , 2017, Proceedings of the National Academy of Sciences.
[12] R. Moffitt,et al. Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer , 2016, Oncotarget.
[13] M. Zucchetti,et al. 3D Mass Spectrometry Imaging Reveals a Very Heterogeneous Drug Distribution in Tumors , 2016, Scientific Reports.
[14] L. Cantley,et al. Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion , 2016, Nature.
[15] Sathesh Bhat,et al. Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small cell lung cancer in preclinical models , 2016, Nature Medicine.
[16] R. Gillies,et al. MR Imaging Biomarkers to Monitor Early Response to Hypoxia-Activated Prodrug TH-302 in Pancreatic Cancer Xenografts , 2016, PloS one.
[17] C. Benelli,et al. The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents , 2016, International journal of cancer.
[18] B. Faubert,et al. Metabolic Heterogeneity in Human Lung Tumors , 2016, Cell.
[19] C. Thompson,et al. The Emerging Hallmarks of Cancer Metabolism. , 2016, Cell metabolism.
[20] J. Mayerle,et al. Approaching Pancreatic Cancer Phenotypes via Metabolomics , 2016 .
[21] E. Ananieva. Targeting amino acid metabolism in cancer growth and anti-tumor immune response. , 2015, World journal of biological chemistry.
[22] C. H. Nielsen,et al. The use of dynamic nuclear polarization (13)C-pyruvate MRS in cancer. , 2015, American journal of nuclear medicine and molecular imaging.
[23] E. Ruppin,et al. Diversion of aspartate in ASS1-deficient tumors fosters de novo pyrimidine synthesis , 2015, Nature.
[24] Anneleen Daemen,et al. Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors , 2015, Proceedings of the National Academy of Sciences.
[25] M. Hidalgo,et al. Pancreatic cancer: from state-of-the-art treatments to promising novel therapies , 2015, Nature Reviews Clinical Oncology.
[26] M. V. Vander Heiden,et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. , 2015, Cancer research.
[27] R. Gillies,et al. Evaluation of the “Steal” Phenomenon on the Efficacy of Hypoxia Activated Prodrug TH-302 in Pancreatic Cancer , 2014, PloS one.
[28] M. Tempero,et al. HR‐MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer , 2014, NMR in biomedicine.
[29] James B. Mitchell,et al. In vivo imaging of tumor physiological, metabolic, and redox changes in response to the anti-angiogenic agent sunitinib: longitudinal assessment to identify transient vascular renormalization. , 2014, Antioxidants & redox signaling.
[30] Channing J Der,et al. KRAS: feeding pancreatic cancer proliferation. , 2014, Trends in biochemical sciences.
[31] A. Joubert,et al. Tumor cell culture survival following glucose and glutamine deprivation at typical physiological concentrations. , 2014, Nutrition.
[32] A. Darzi,et al. Chemical mapping of the colorectal cancer microenvironment via MALDI imaging mass spectrometry (MALDI‐MSI) reveals novel cancer‐associated field effects , 2014, Molecular oncology.
[33] Y. Kloog,et al. Metabolism addiction in pancreatic cancer , 2014, Cell Death and Disease.
[34] R. Deberardinis,et al. Simultaneous Steady-state and Dynamic 13C NMR Can Differentiate Alternative Routes of Pyruvate Metabolism in Living Cancer Cells* , 2014, The Journal of Biological Chemistry.
[35] Mikko I. Kettunen,et al. Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C-labeled glucose , 2013, Nature Medicine.
[36] E. Taylor,et al. Regulation of pyruvate metabolism and human disease , 2013, Cellular and Molecular Life Sciences.
[37] Martin O. Leach,et al. Model Free Approach to Kinetic Analysis of Real-Time Hyperpolarized 13C Magnetic Resonance Spectroscopy Data , 2013, PloS one.
[38] R. Deberardinis,et al. The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling. , 2013, Molecular cell.
[39] R. Tomasini,et al. Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma , 2013, Proceedings of the National Academy of Sciences.
[40] J. Fangusaro. Pediatric High Grade Glioma: a Review and Update on Tumor Clinical Characteristics and Biology , 2012, Front. Oncol..
[41] Tomoyoshi Soga,et al. The emerging role of fumarate as an oncometabolite , 2012, Front. Oncol..
[42] Gerald C. Chu,et al. Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.
[43] P. Ward,et al. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.
[44] Damien J. Ferraro,et al. TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules , 2012, Cancer Chemotherapy and Pharmacology.
[45] Marc Liesa,et al. Pancreatic cancers require autophagy for tumor growth. , 2011, Genes & development.
[46] J. Shea,et al. Phenotype and Genotype of Pancreatic Cancer Cell Lines , 2010, Pancreas.
[47] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[48] Douglas B. Evans,et al. Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice , 2009, Nature Protocols.
[49] Julien Verrax,et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.
[50] Jacco D. van Beek,et al. matNMR: A flexible toolbox for processing, analyzing and visualizing magnetic resonance data in Matlab® , 2007 .
[51] J. V. van Beek,et al. matNMR: a flexible toolbox for processing, analyzing and visualizing magnetic resonance data in Matlab. , 2007, Journal of magnetic resonance.
[52] Manuel Martín-Pastor,et al. A new general-purpose fully automatic baseline-correction procedure for 1D and 2D NMR data. , 2006, Journal of magnetic resonance.
[53] K K Jain,et al. Personalised medicine for cancer: from drug development into clinical practice , 2005, Expert opinion on pharmacotherapy.
[54] P. Eilers. A perfect smoother. , 2003, Analytical chemistry.
[55] Zhiqiang Weng,et al. Communication An efficient algorithm for automatic phase correction of NMR spectra based on entropy minimization , 2002 .
[56] A. Koong,et al. Pancreatic tumors show high levels of hypoxia. , 2000, International journal of radiation oncology, biology, physics.
[57] Rasmus Bro,et al. The N-way Toolbox for MATLAB , 2000 .
[58] Joos Vandewalle,et al. On the Best Rank-1 and Rank-(R1 , R2, ... , RN) Approximation of Higher-Order Tensors , 2000, SIAM J. Matrix Anal. Appl..
[59] C. Garlanda,et al. Involvement of endothelial PECAM-1/CD31 in angiogenesis. , 1997, The American journal of pathology.
[60] H. Lyng,et al. Detection of necrosis in human tumour xenografts by proton magnetic resonance imaging. , 1995, British Journal of Cancer.
[61] R Gruetter,et al. Automatic, localized in Vivo adjustment of all first‐and second‐order shim coils , 1993, Magnetic resonance in medicine.
[62] A. Bax,et al. Improved linear prediction of damped NMR signals using modified forward-backward linear prediction , 1992 .
[63] Joel R. Levin,et al. New developments in pairwise multiple comparisons : some powerful and practicable procedures , 1991 .
[64] W. Dietrich,et al. Fast and precise automatic baseline correction of one- and two-dimensional nmr spectra , 1991 .
[65] J Hennig,et al. RARE imaging: A fast imaging method for clinical MR , 1986, Magnetic resonance in medicine.
[66] Ray Freeman,et al. Broadband Decoupling in High-Resolution Nuclear Magnetic Resonance Spectroscopy , 1984 .
[67] Ray Freeman,et al. Supercycles for broadband heteronuclear decoupling , 1982 .
[68] S. Holm. A Simple Sequentially Rejective Multiple Test Procedure , 1979 .